|
|
Volumn 5, Issue 3, 2007, Pages 261-
|
|
Targeted therapy of dermatofibrosarcoma with imatinib;Arbeitsgemeinschaft dermatologische onkologie ADO
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IMATINIB;
ANTINEOPLASTIC AGENT;
PIPERAZINE DERIVATIVE;
PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;
PROTEIN KINASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
ARTICLE;
CANCER SURGERY;
CHROMOSOME ABERRATION;
CHROMOSOME TRANSLOCATION;
CLINICAL TRIAL;
DERMATOFIBROSARCOMA PROTUBERANS;
GENE FUSION;
HISTOLOGY;
HUMAN;
PREVALENCE;
TUMOR GROWTH;
ADULT;
AGED;
DISEASE FREE SURVIVAL;
DRUG DELIVERY SYSTEM;
FEMALE;
GENE REARRANGEMENT;
GENETICS;
MALE;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
PHASE 2 CLINICAL TRIAL;
SKIN TUMOR;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
CHROMOSOME ABERRATIONS;
CLINICAL TRIALS, PHASE II;
DERMATOFIBROSARCOMA;
DISEASE-FREE SURVIVAL;
DRUG DELIVERY SYSTEMS;
FEMALE;
GENE REARRANGEMENT;
HUMANS;
MALE;
MIDDLE AGED;
PIPERAZINES;
PROTEIN KINASE INHIBITORS;
PYRIMIDINES;
RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA;
SKIN NEOPLASMS;
|
|
EID: 33847659234
PISSN: 16100379
EISSN: 16100387
Source Type: Journal
DOI: 10.1111/j.1610-0387.2007.07009.x Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
